Nano Dimension | 1.93 +0.17 +9.66% | ||
| NNDM | |||
| 高 2.00 | 开 1.77 | 量 495.77万股 | 总市值 4.06亿 |
| 低 1.76 | 换 2.36% | 额 949.72万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Nano Dimension(NNDM)
02-03 19:15
$Nano Dimension(NNDM)$ 8-K Current report, items 1.01, 3.01, 8.01, and 9.01 Accession Number: 0001104659-26-009481 Act: 34 Size: 287 KB 网页链接
Nano Dimension(NNDM)
02-03 19:15
$Nano Dimension(NNDM)$ 8-A12B Registration of securities [Section 12(b)] Accession Number: 0001104659-26-009462 Act: 34 Size: 263 KB 网页链接
Nano Dimension(NNDM)
2025-11-20 05:15
$Nano Dimension(NNDM)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-114088 Act: 34 Size: 313 KB 网页链接
Nano Dimension(NNDM)
01-21 21:35
$Nano Dimension(NNDM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-26-005254 Act: 34 Size: 255 KB 网页链接
Nano Dimension(NNDM)
01-30 05:45
$Nano Dimension(NNDM)$ SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership Accession Number: 0001213900-26-009570 Act: 34 Size: 39 KB 网页链接
Nano Dimension(NNDM)
2025-11-21 05:55
$Nano Dimension(NNDM)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-114642 Act: 34 Size: 83 KB 网页链接
Nano Dimension(NNDM)
2025-12-05 05:25
$Nano Dimension(NNDM)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-118460 Act: 34 Size: 47 KB 网页链接
Siph2018
01-30 17:02
$Nano Dimension(NNDM)$ Oramed Pharmaceuticals Inc. 和 Nadav Kidron 联合提交了关于他们持有Nano Dimension Ltd.普通股受益所有权的Schedule 13D表格。截至2026年1月29日，Oramed Pharmaceuticals Inc. 受益持有10,413,730股，占已发行股份的5.0%。Nadav Kidron 受益持有10,549,430股，同样占已...